We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
WuXi Diagnostic Investment (Cayman) Limited announced that it has completed US$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc., Shiyu Capital, ABC International Holdings Limited, Sunland Capital and ...
WuXi Diagnostics' researchers and technicians will leverage this facility to optimize existing diagnostic tests and to collaborate in the development of new diagnostic tests with Mayo Clinic's Department of Laboratory Medicine and Pathology, specifically